

Cover Story
Free
By Paul Goldberg and Matthew Bin Han Ong
A foundation established by Silicon Valley entrepreneur Sean Parker—founder of Napster and first president of Facebook—has committed $250 million to research in cancer immunotherapy.
In Brief


Drugs & Targets
Trending Stories
- Charles Rudin named cancer center director at MSK
- Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- FDA’s acting drug chief, acting vaccines chief, and chief of staff ousted in the wake of Makary departure
- Marcel van den Brink: Microbiome research is now in “critical phase” where evidence points to therapeutic use
- NCI’s Letai gets softball questions from Senate appropriators at an otherwise contentious hearing











